Clinical Trials

Showing trials with last updates posted in 2024.

NCT06398587 | WITHDRAWN | PHASE2
0 participants

Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2024-07-19
Start Date:
2024-08-01
Completion:
2026-05-04
Conditions
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Stage II Pancreatic Cancer AJCC v8
  • Stage III Pancreatic Cancer AJCC v8
  • Stage IV Pancreatic Cancer AJCC v8
  • Unresectable Pancreatic Adenocarcinoma
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT05839431 | COMPLETED | NA
10 participants

Virtual Reality for Youth Phobias

Study Type:
INTERVENTIONAL
Last Updated:
2024-07-19
Start Date:
2023-07-14
Completion:
2024-03-31
Conditions
  • Specific Phobia
  • Social Anxiety Disorder
  • Autism Spectrum Disorder
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page